TLOG OTC
TetraLogic Pharmaceuticals Corporation
1W: +0.0%
1M: +150.0%
3M: +150.0%
YTD: +0.0%
1Y: -50.0%
3Y: -98.0%
5Y: -99.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$188K
+0.0% ▲
Operating Income
-$45M
-33.2% ▼
Net Income
-$56M
-42.7% ▼
EPS (Diluted)
$-2.36
-34.1% ▼
EBITDA
-$43M
-32.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $188K |
| Gross Profit | $0 | $0 | $0 | $0 | -$188K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $15M | $12M | $10M | $20M | $27M |
| SG&A Expenses | $4M | $4M | $8M | $11M | $11M |
| Operating Expenses | $19M | $16M | $18M | $31M | $39M |
| Operating Income | -$19M | -$16M | -$18M | -$34M | -$45M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $7K | $73K | $3M | $3M | $6M |
| Income Before Tax | -$19M | -$16M | -$20M | -$36M | -$50M |
| Tax Expense | $7K | $73K | $3M | $3M | $6M |
| Net Income | -$19M | -$16M | -$23M | -$39M | -$56M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-14.80 | $-16.78 | $-9.90 | $-1.76 | $-2.36 |
| EBITDA | -$19M | -$16M | -$17M | -$32M | -$43M |
| Shares Outstanding | 1M | 969998 | 2M | 22M | 24M |